Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:04 AM
Ignite Modification Date:
2025-12-25 @ 1:04 AM
NCT ID:
NCT02243293
Eligibility Criteria:
Inclusion Criteria:
* Screening laboratory result indicating HCV Genotype 2, 3, 4, 5, or 6 infection.
* Chronic HCV infection.
* Participant had to be either HCV treatment-naïve or treatment-experienced.
* Participant had to be documented as non-cirrhotic or as having compensated cirrhosis (GT3 only).
Exclusion Criteria:
* History of severe, life-threatening or other significant sensitivity to any drug.
* Female who was pregnant, planning to become pregnant during the study, or breastfeeding; or male whose partner was pregnant or planning to become pregnant during the study.
* Recent (within 6 months prior to study drug administration) history of drug or alcohol abuse that could preclude adherence to the protocol in the opinion of the investigator.
* Positive test result at Screening for hepatitis B surface antigen (HBsAg) or anti-human immunodeficiency virus antibody (HIV Ab).
* HCV genotype performed during screening indicating co-infection with more than one HCV genotype.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02243293
Study Brief:
Protocol Section:
NCT02243293